Barclays’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
Barclays's TNDM Position: Q3 2026 in Review
Barclays increased its Tandem Diabetes Care (TNDM) stake by 21% in Q3 2026, buying an estimated $1.4M and bringing the position to 425,185 shares worth $6.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1866.
Barclays first reported a position in TNDM in Q4 2013 and has held it in 49 quarters since. The position peaked at $20.2M in Q4 2025. 267 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.
- Barclays held 425,185 shares of Tandem Diabetes Care worth $6.93M as of Q3 2026.
- Barclays bought 74,756 Tandem Diabetes Care shares in Q3 2026, an estimated $1.4M.
- Tandem Diabetes Care made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1866 holding.
- Barclays first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 49 quarters since.
- Barclays's Tandem Diabetes Care position peaked at $20.2M in Q4 2025.
- 267 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.